What is the equity of Kancera this year?
Kancera has equity of 47.67 M SEK this year.
Kancera Equity 2024
Kancera Equity
47.67 M SEK
Ticker
KAN.ST
ISIN
SE0015658570
WKN
A2QQQ4
In 2024, Kancera's equity was 47.67 M SEK, a -55.42% increase from the 106.91 M SEK equity in the previous year.
Kancera Aktienanalyse
What does Kancera do?
Kancera ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Kancera's Equity
Kancera's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Kancera's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Kancera's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Kancera's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Kancera’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Kancera stock
What was the equity of Kancera compared to the previous year?
The equity of Kancera has increased/decreased by -55.42% decreased compared to the previous year.
What impact does a high equity have on investors of Kancera?
A high equity is advantageous for investors of Kancera as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Kancera?
A low equity can be a risk for investors of Kancera, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Kancera affect the company?
An increase in equity of Kancera can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Kancera affect the company?
A reduction in equity of Kancera can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Kancera?
Some factors that can affect the equity of Kancera include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Kancera so important for investors?
The equity of Kancera is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Kancera take to change the equity?
To change equity, Kancera can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Kancera pay?
Over the past 12 months, Kancera paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Kancera is expected to pay a dividend of 0 SEK.
What is the dividend yield of Kancera?
The current dividend yield of Kancera is .
When does Kancera pay dividends?
Kancera pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Kancera?
Kancera paid dividends every year for the past 0 years.
What is the dividend of Kancera?
For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.
In which sector is Kancera located?
Kancera is assigned to the 'Health' sector.
Wann musste ich die Aktien von Kancera kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Kancera from 7/31/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 7/31/2024.
When did Kancera pay the last dividend?
The last dividend was paid out on 7/31/2024.
What was the dividend of Kancera in the year 2023?
In the year 2023, Kancera distributed 0 SEK as dividends.
In which currency does Kancera pay out the dividend?
The dividends of Kancera are distributed in SEK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Kancera
Our stock analysis for Kancera Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kancera Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.